[ad_1]
The University of Oxford has also confirmed plans to continue vaccination.
In a statement, they said that after careful scrutiny, there were no longer any concerns about the safety of the clinical trial.
According to the Brazilian newspaper O’Globo, the volunteer was given a placebo (empty medicine), not a test vaccine.
Brazilian health authorities have said they will maintain the medical confidentiality of participants in the Anvisa vaccine trial, without giving further details.
Astrajenka also did not immediately comment on the matter.
The Federal University of São Paulo, which assisted in the third phase of clinical trials of the AstraZeneca-Oxford vaccine in Brazil, said the deceased volunteer was a Brazilian citizen. However, they did not say where he lived.
Previously, the trial was temporarily suspended after a participant in the UK fell ill from the Astragenka-Oxford vaccine trial.
AstraZeneca vaccine trials in the United States have been closed since September 6. Rumor has it that he may start over this week.
The Brazilian government plans to buy the vaccine and produce it at its own biomedical research center.
On the other hand, another vaccine from the Chinese Sinovac Biotech Limited is being tested at a research center in the state of São Paulo.
More than 154,000 people have died from Covid-19 in Brazil so far. Brazil ranks second after the United States in the death toll.
And in terms of infection, Brazil is behind the United States and India. The number of identified patients in the country is more than 52 lakh.
[ad_2]
